Too early to bet against AI trade, State Street suggests

State Street is reaffirming its positive outlook on artificial intelligence investments, even as the Nasdaq experiences its most challenging week since April. Anna Paglia, the firm's chief business officer, emphasizes that momentum stocks continue to show potential, as investors remain eager to engage with the growth narrative that has powered market gains throughout the year. "Why would anyone want to miss out on the advancement of AI technology? There's been a widespread anticipation for a shift from growth to value investing, but I don't foresee that transition happening anytime soon due to the current momentum," Paglia stated during her appearance on CNBC's "ETF Edge" this week. She believes that a significant market signal indicating a slowdown in these robust trends is necessary before any rebalancing occurs. With over 25 years of experience in the exchange-traded funds sector, Paglia predicts a greater emphasis on diversification as early as next year. State Street manages multiple ETFs that are invested in the technology sector, including the SPDR NYSE Technology ETF, which has seen a remarkable 38% increase this year. However, the fund faced a setback of more than 4% in the past week, as investors took profits from AI-related stocks. Notably, Palantir Technologies, one of the fund's top holdings, reported earnings recently but saw its stock fall by over 11% this week. Despite these challenges, Paglia remains confident in the technology sector's potential, reaffirming her bullish stance in subsequent statements to CNBC. In contrast, Todd Rosenbluth, head of research at State Street, notes that a market rotation may already be underway, highlighting a renewed interest in healthcare stocks. "The Health Care Select Sector SPDR Fund, which had been out of favor for much of the year, has started to gain traction in October," he remarked during the same interview. With healthcare often viewed as a more defensive investment, Rosenbluth is keen to see if this trend continues, as investors look to diversify away from the technology sector. The Health Care Select Sector SPDR Fund has risen by 5% since October 1, emerging as the second-best performing S&P 500 group this week.